Jenny Rubin

605 total citations
14 papers, 480 citations indexed

About

Jenny Rubin is a scholar working on Oncology, Immunology and Microbiology. According to data from OpenAlex, Jenny Rubin has authored 14 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Microbiology. Recurrent topics in Jenny Rubin's work include Antimicrobial Peptides and Activities (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Immune Cell Function and Interaction (3 papers). Jenny Rubin is often cited by papers focused on Antimicrobial Peptides and Activities (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Immune Cell Function and Interaction (3 papers). Jenny Rubin collaborates with scholars based in Sweden, Russia and Denmark. Jenny Rubin's co-authors include Per Venge, Shengyuan Xu, Wenyu Han, Linjun Cai, Rolf Larsson, Mårten Fryknäs, Peter Nygren, Malin Jarvius, Malin Berglund and Wojciech Senkowski and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and FEBS Journal.

In The Last Decade

Jenny Rubin

14 papers receiving 472 citations

Peers

Countries citing papers authored by Jenny Rubin

Since Specialization

Citations

This map shows the geographic impact of Jenny Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Rubin more than expected).

Fields of papers citing papers by Jenny Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Rubin. The network helps show where Jenny Rubin may publish in the future.

Co-authorship network of co-authors of Jenny Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Rubin. A scholar is included among the top collaborators of Jenny Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Rubin. Jenny Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway 2020 ·Scientific Reports ·Claes Andersson, (unknown), (unknown), Jenny Rubin, Malin Berglund, Malin Jarvius, (unknown), Vendela Parrow, Angelica Loskog, Mårten Fryknäs, Peter Nygren, Rolf Larsson	12
2	Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids 2020 ·ACS Omega ·Julia Steinmetz, Wojciech Senkowski, Johan Lengqvist, Jenny Rubin, Elena Ossipova, Stephanie Herman, Rolf Larsson, Per‐Johan Jakobsson, Mårten Fryknäs, Kim Kultima	7
3	Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition 2019 ·BMC Research Notes ·(unknown), Jenny Rubin, Malin Berglund, Malin Jarvius, (unknown), Vendela Parrow, Claes Andersson, Angelica Loskog, Mårten Fryknäs, Peter Nygren, Rolf Larsson	18
4	Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing 2018 ·Oncotarget ·Jenny Rubin, (unknown), (unknown), Malin Berglund, (unknown), Claes Andersson, Angelica Loskog, Mårten Fryknäs, Peter Nygren, Rolf Larsson	17
5	The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation 2017 ·Immunopharmacology and Immunotoxicology ·(unknown), Wojciech Senkowski, Malin Jarvius, Malin Berglund, Jenny Rubin, (unknown), Vendela Parrow, Claes Andersson, Angelica Loskog, Mårten Fryknäs, Peter Nygren, Rolf Larsson	23
6	Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids 2016 ·Cell chemical biology ·Wojciech Senkowski, Malin Jarvius, Jenny Rubin, Johan Lengqvist, Mats G. Gustafsson, Peter Nygren, Kim Kultima, Rolf Larsson, Mårten Fryknäs	28
7	Protein post‐translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms 2014 ·FEBS Journal ·(unknown), Jenny Rubin, Mohammed Moussaoui, David Pulido, M. Victòria Nogués, Per Venge, Ester Boix	16
8	Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP) 2013 ·Molecular Immunology ·Jenny Rubin, Per Venge	6
9	Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma - a population-based study 2011 ·European Journal Of Haematology ·Ingrid Glimelius, Jenny Rubin, Klaus Rostgaard, Rose‐Marie Amini, Martin Simonsson, Karina M. Sørensen, Karin E. Smedby, Per Venge, Henrik Hjalgrim, Daniel Molin, Gunilla Enblad	22
10	Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines 2011 ·Experimental Hematology ·Ingrid Glimelius, Jenny Rubin, Marie Fischer, Daniel Molin, Rose‐Marie Amini, Per Venge, Gunilla Enblad	20
11	The Origin of Multiple Molecular Forms in Urine of HNL/NGAL 2010 ·Clinical Journal of the American Society of Nephrology ·Linjun Cai, Jenny Rubin, Wenyu Han, Per Venge, Shengyuan Xu	222
12	The Coding ECP 434(G>C) Gene Polymorphism Determines the Cytotoxicity of ECP but Has Minor Effects on Fibroblast-Mediated Gel Contraction and No Effect on RNase Activity 2009 ·The Journal of Immunology ·Jenny Rubin, Ulrika Zagai, (unknown), (unknown), Åke Engström, Per Venge	23
13	Eosinophil Cationic Protein (ECP) Is Processed during Secretion 2009 ·The Journal of Immunology ·(unknown), Jenny Rubin, Per Venge	47
14	Crohn's disease of the esophagus. 1994 ·PubMed ·(unknown), (unknown), Jenny Rubin	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact